XTL Biopharmaceuticals Ltd (XTLB) stock
XTLBNasdaqPharmaceutical Preparations
$1.60−0.04 (-2.44%)
Close on Nov 13, 2026Market cap $15.14MP/E –Yield –
XTL Biopharmaceuticals total assets
Total assets on the balance sheet at the end of each period.
XTL Biopharmaceuticals's total assets was $166.00K at Dec 31, 2025. For fiscal 2025 it was $166.00K, down 98.1% from the year before. The highest annual figure on record is $8.58M in fiscal 2018.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $166.00K | -98.1% |
| FY2024 | Dec 31, 2024 | $8.55M | +252.4% |
| FY2023 | Dec 31, 2023 | $2.43M | -42.0% |
| FY2022 | Dec 31, 2022 | $4.19M | -36.7% |
| FY2021 | Dec 31, 2021 | $6.62M | +1.8% |
| FY2020 | Dec 31, 2020 | $6.50M | -9.8% |
| FY2019 | Dec 31, 2019 | $7.21M | -15.9% |
| FY2018 | Dec 31, 2018 | $8.58M | +30.2% |
| FY2017 | Dec 31, 2017 | $6.59M | +118.3% |
| FY2016 | Dec 31, 2016 | $3.02M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | $166.00K | -97.1% |
| Q4 FY2024 | Dec 31, 2024 | $8.55M | +29.2% |
| Q4 FY2023 | Dec 31, 2023 | $2.43M | -65.1% |
| Q4 FY2022 | Dec 31, 2022 | $4.19M | -35.6% |
| Q2 FY2022 | Jun 30, 2022 | $5.76M | -20.2% |
| Q4 FY2021 | Dec 31, 2021 | $6.62M | -22.8% |
| Q2 FY2021 | Jun 30, 2021 | $6.95M | +5.6% |
| Q4 FY2020 | Dec 31, 2020 | $6.50M | +115.5% |
| Q4 FY2019 | Dec 31, 2019 | $7.21M | – |
| Q4 FY2018 | Dec 31, 2018 | $8.58M | – |
| Q4 FY2017 | Dec 31, 2017 | $6.59M | – |
| Q4 FY2016 | Dec 31, 2016 | $3.02M | – |
See a number that looks wrong?